Lewis Miller
Neurology with Special Qualifications in Child Neurology · Chattanooga, TNNPI 1144403171
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,829 of the $7,610 with a category attached, or 76.6%. It is spread thinly across 36 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,462 and has fallen 55.1% since, to $1,106 in 2025.
Across 239 payments — averaging $31.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$2K
- UCB, Inc.$1K
- Neurelis, Inc.$876
- Jazz Pharmaceuticals Inc.$578
- Eisai Inc.$294
- Greenwich Biosciences, Inc.$270
- plus $2K from 30 others
Across 14 payments — averaging $1883.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Biopharmaceuticals, Inc$26K
What the payments were for
- Consulting fees$3505%
- Speaking & faculty fees$1,40018%
- Food & beverage$5,82977%
- Education$160%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 6 | $1,813 |
| UCB, Inc. | 48 | $1,354 |
| Neurelis, Inc. | 22 | $876 |
| Jazz Pharmaceuticals Inc. | 24 | $578 |
| Eisai Inc. | 16 | $294 |
| Greenwich Biosciences, Inc. | 6 | $270 |
| Genentech, Inc. | 3 | $263 |
| Biogen | 8 | $259 |
| Supernus Pharmaceuticals, Inc. | 18 | $183 |
| Sunovion Pharmaceuticals Inc. | 21 | $178 |
| Genentech USA, Inc. | 4 | $148 |
| AbbVie | 7 | $141 |
| Catalyst Pharmaceuticals, Inc. | 5 | $121 |
| Aucta Pharmaceuticals, Inc. | 5 | $121 |
| Immedica Pharma US, Inc. | 4 | $117 |
| Acadia Pharmaceuticals Inc | 4 | $101 |
| SK Life Science, Inc. | 4 | $81 |
| Novartis | 3 | $76 |
| Sumitomo Pharma America, Inc. | 4 | $70 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 3 | $66 |
| Upsher-smith Laboratories LLC | 2 | $54 |
| Otter Pharmaceuticals, LLC | 2 | $53 |
| Sarepta Therapeutics, Inc. | 2 | $52 |
| Saol Therapeutics Inc. | 3 | $45 |
| NS Pharma, Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Aquestive Therapeutics, Inc. | 2 | $32 |
| Biocodex, Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| AstraZeneca | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Metacel Pharmaceuticals LLC | 1 | $20 |
| Sanofi | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Medtronic | 1 | $18 |
| Zogenix Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,610 in reported general payments places this provider in the 70th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.
See all neurology with special qualifications in child neurology providers in Tennessee →
Other neurology with special qualifications in child neurology in Chattanooga
- Thomas IrelandChattanooga$120K
- Day BreenChattanooga$8K
- Laura ThomasChattanooga$3K
- Jesus Pina GarzaNashville$1.4M
- James WhelessMemphis$1.2M
- Richard FinkelMemphis$353K
- Jeffrey NeulNashville$127K
- James FryNashville$80K
- Willie AndersonJohnson City$26K
- William BurnetteNashville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.